Please use this identifier to cite or link to this item:
Title: Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: A 17-year study
Authors: Crespo-Ortiz, Maria del Pilar
Castañeda-Ramírez, Claudia Rocío
Recalde-Bolaños, Monica
Vélez-Londoño, Juan Diego
Keywords: Bacteremia
Group B Streptococcus
Neonatal infections
Streptococcus agalactiae
Aged, 80 and over
Anti-Bacterial Agents
Cross-Sectional Studies
Drug Resistance, Bacterial
Hospitals, University
Microbial Sensitivity Tests
Middle Aged
Retrospective Studies
Streptococcal Infections
Young Adult
Issue Date: 3-Aug-2014
Publisher: BioMed Central Ltd.
Abstract: Background: Streptococcus agalactiae or group B Streptococcus (GBS) has been recognized as a lethal pathogen in neonates worldwide. S. agalactiae infections also severely affect pregnant women and immunosuppressed adults with substantial attributable morbidity and mortality. However, in Latin America, studies on the epidemiology and behaviour of S. agalactiae infections remain limited.Methods: To better understand the behaviour of S. agalactiae infections in our region, we conducted a retrospective study to phenotypically describe S. agalactiae isolates collected in one of the largest hospitals in Colombia at two time periods: 1994-2001 and 2004-2012. The isolates were identified by biochemical analysis and tested for antimicrobial susceptibility.Results: In 1994-2001 a total of 201 S. agalactiae isolates were found in urine 38.3%, vaginal exudates 27.8%, soft tissue 12.9%, and blood 8.5%. Susceptibility to ampicillin or penicillin was 94% whereas resistance to erythromycin and clindamycin were 2.8% and 5.2% respectively. In total 46 culture-positive cases of invasive infections were reported, 11 (24%) in neonates and 35 (76%) in adults. In 2004-2012 a total of 671 isolates were found in urine 47.8%, vaginal exudates 32.6%, soft tissue 2.7% and blood 9%. Susceptibility rates to ampicillin and penicillin were 98% whereas resistance to erythromycin and clindamycin were 12.5% and 9.4%. A total of 95 severe infections were reported: 12 (12.6%) were in neonates, 5 (5.3%) in children and 78 (82.1%) in adults. Over the 17-year study period the averaged prevalence of invasive S. agalactiae isolates was 17.4%. The estimated incidence for neonatal infections was 1.34 per 1000 livebirths (0.99 × 1000 livebirths for early- onset disease and 0.35 × 1000 livebirths for late- onset disease) whereas for non-pregnant adults the estimated incidence was 0.75 × 1000 admissions.Conclusions: A remarkable increase in bloodstream infections in immunosuppressed adults and a shift to early neonatal S. agalactiae infections were seen over time. We also found an increase in S. agalactiae resistance to erythromycin and clindamycin during the study period, and the emergence of penicillin-nonsusceptible isolates. Our findings are consistent with the global trends described elsewhere, reinforcing the need for S. agalactiae control measures in our region. © 2014 Crespo-Ortiz et al.; licensee BioMed Central Ltd.
ISSN: 14712334
Appears in Collections:Artículos Científicos

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.